Notice Type
Departmental
Notice Title

Revocation of Consent to the Distribution of Medicines

Pursuant to section 35(1) of the Medicines Act 1981, the Minister of Health hereby revokes the consent to the distribution of the medicines in New Zealand granted under section 20 of the Act for the following medicines:

Schedule

Product: Duro-Tuss Phenylephrine PE Dry Cough + Nasal Decongestant
Active Ingredients: Phenylephrine hydrochloride 0.667mg/mL
Pholcodine 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Ensign Laboratories Pty Limited, Melbourne, Australia
   
Product: Difflam Plus Cough Sore Throat Lozenges (Sugar Free Honey, Lemon & Ginger Flavour)
Active Ingredients: Pholcodine 5.5mg
Benzydamine hydrochloride 1.5mg
Cetylpyridinium chloride 1.33mg
Dosage Form: Lozenge
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Unique Pharmaceuticals Laboratories, Kadaiya, India
   
Product: Difflam Plus Cough Sore Throat Lozenges (Sugar Free Pineapple & Lime Flavour)
Active Ingredients: Pholcodine 5.5mg
Benzydamine hydrochloride 1.5mg
Cetylpyridinium chloride 1.33mg
Dosage Form: Lozenge
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Unique Pharmaceuticals Laboratories, Kadaiya, India
   
Product: Strong Pholcodine Linctus BP
Active Ingredient: Pholcodine 2mg/mL
Dosage Form: Linctus
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Pinewood Laboratories Limited, Clonmel, Ireland
   
Product: Duro-Tuss Dry Cough Liquid Forte
Active Ingredient: Pholcodine 3mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Ensign Laboratories Pty Limited, Melbourne, Australia
   
Product: Duro-Tuss Dry Cough (Orange)
Active Ingredients: Pholcodine 5.5mg
Cetylpyridinium chloride monohydrate 1.33mg
Dosage Form: Lozenge
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Unique Pharmaceuticals Laboratories, Kadaiya, India
   
Product: Duro-Tuss Dry Cough Liquid Junior (New Formula)
Active Ingredient: Pholcodine 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Ensign Laboratories Pty Limited, Melbourne, Australia
   
Product: Duro-Tuss Cough Liquid Expectorant
Active Ingredients: Bromhexine hydrochloride 0.8mg/mL
Pholcodine 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Ensign Laboratories Pty Limited, Melbourne, Australia
   
Product: Duro-Tuss Dry Cough Liquid Regular (New Formula)
Active Ingredient: Pholcodine 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Ensign Laboratories Pty Limited, Melbourne, Australia
   
Product: Pholcodine Linctus BP
Active Ingredient: Pholcodine 1mg/mL
Dosage Form: Linctus
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Pinewood Laboratories Limited, Clonmel, Ireland
   
Product: Difflam Plus Dry Cough + Antibacterial + Anti-inflammatory (Blackcurrant Flavour Sugar Free)
Active Ingredients: Benzydamine hydrochloride 1.5mg
Pholcodine 5.5mg
Cetylpyridinium chloride monohydrate 1.33mg
Dosage Form: Lozenge
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Unique Pharmaceuticals Laboratories, Kadaiya, India
   
Product: Duro-Tuss Dry Cough (Lemon)
Active Ingredients: Pholcodine 5.5mg
Cetylpyridinium chloride monohydrate 1.33mg
Dosage Form: Lozenge
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Unique Pharmaceuticals Laboratories, Kadaiya, India
   
Product: Stubborn Dry Tickly Cough (Pharmacy Health)
Active Ingredient: Pholcodine 2mg/mL
Dosage Form: Linctus
New Zealand Sponsor: Noumed Pharmaceuticals Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand


Dated this 22nd day of December 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).